J. Sehouli, I. Vergote, Erika Hamilton, Alejandro Pérez Fidalgo, T. Gorp, G. Scambia, Jaroslav Klát, Tally Levy, S. Welch, Debra L Richardson, Eva Maria Guerra Alía, Stéphanie Henry, P. Wimberger, David S Miller, Jerónimo Martínez, Bradley J. Monk, Pratheek Kalyanapu, M.R. Mirza, Vicky Makker
{"title":"187 TP53wt晚期或复发性子宫内膜癌患者的Selinexor维持治疗:ENGOT-EN5/GOG-3055/SIENDO研究疗效和安全性亚组分析的长期随访","authors":"J. Sehouli, I. Vergote, Erika Hamilton, Alejandro Pérez Fidalgo, T. Gorp, G. Scambia, Jaroslav Klát, Tally Levy, S. Welch, Debra L Richardson, Eva Maria Guerra Alía, Stéphanie Henry, P. Wimberger, David S Miller, Jerónimo Martínez, Bradley J. Monk, Pratheek Kalyanapu, M.R. Mirza, Vicky Makker","doi":"10.1136/ijgc-2024-esgo.20","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"8 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study\",\"authors\":\"J. Sehouli, I. Vergote, Erika Hamilton, Alejandro Pérez Fidalgo, T. Gorp, G. Scambia, Jaroslav Klát, Tally Levy, S. Welch, Debra L Richardson, Eva Maria Guerra Alía, Stéphanie Henry, P. Wimberger, David S Miller, Jerónimo Martínez, Bradley J. Monk, Pratheek Kalyanapu, M.R. Mirza, Vicky Makker\",\"doi\":\"10.1136/ijgc-2024-esgo.20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517822,\"journal\":{\"name\":\"Oral Sessions\",\"volume\":\"8 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral Sessions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2024-esgo.20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study